Researchers in the groups of Prof. Tobias Gulder from TU Dresden and Prof. Tanja Gulder from Leipzig University have succeeded in understanding the biosynthetic mechanisms for the production of the natural product cyanobacterin, which in Nature is produced in small quantities by the cyanobacteria Scytonema hofmanni.
Research drawing on the national Overcoming COVID-19 study, led by Boston Children’s Hospital, and the hospital’s own Taking On COVID-19 Together Group provides evidence that children who previously had COVID-19 (or the inflammatory condition MIS-C) are not protected against the newer Omicron variant.
An estimated 70 percent of primary care physicians reported in a survey that they would still prescribe antibiotics to treat asymptomatic infections based solely on a positive urine specimen.
Smart hearing aids that adapt to the individual needs of the user: for the last four years, the researchers of the Collaborative Research Centre (CRC) Hearing Acoustics have been working towards this goal. Now the German Research Foundation (DFG) has extended the funding of the project.
Millions of people across the world will be better protected from future pandemics thanks to a landmark resolution brought by the UK and Argentina at the World Health Assembly (WHA) in Geneva today (Friday 27 May).
Today (27 May 2022), Parliamentary Under-Secretary of State for Innovation at the Department of Health and Social Care, Lord Kamall, and the Swedish Minister for Education, Anna Ekström, signed a Memorandum of Understanding (MoU) committing the UK and Sweden to ongoing co-operation in the life sciences.
Biological arms races are commonplace in nature. Cheetahs, for example, have evolved a sleek body form that lends itself to rapid running, enabling them to feast upon similarly speedy gazelles, the fastest of which may evade predation.
Autistic individuals are more likely to have chronic mental and physical health conditions, suggests new research from the University of Cambridge. Autistic individuals also report lower quality healthcare than others.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.